Eesti - eesti - Ravimiamet

karo pharma ab - fluokortoloon+lidokaiin - rektaalsuposiit - 1mg+40mg 10tk; 1mg+40mg 3tk; 1mg+40mg 120tk

Eesti - eesti - Ravimiamet

krka d.d. novo mesto - luuderohuleht - siirup - 7mg 1ml 150ml 1tk

Eesti - eesti - Ravimiamet

biologische heilmittel heel gmbh - homöopaatilised preparaadid - salv - 50g 1tk

Eesti - eesti - Ravimiamet

farmak international sp. z o.o. - luuderohuleht - siirup - 7mg 1ml 100ml 1tk

Eesti - eesti - Ravimiamet

glaxosmithkline dungarvan limited - nikotiin - transdermaalne plaaster - 21mg 24h 7tk; 21mg 24h 28tk

Eesti - eesti - Ravimiamet

glaxosmithkline dungarvan limited - nikotiin - transdermaalne plaaster - 7mg 24h 28tk

Eesti - eesti - Ravimiamet

glaxosmithkline dungarvan limited - nikotiin - transdermaalne plaaster - 14mg 24h 28tk; 14mg 24h 7tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Euroopa Liit - eesti - EMA (European Medicines Agency)

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoos, postmenopausis - narkootikumid luuhaiguste raviks - menopausijärgse osteoporoosi ravi d-vitamiini puudulikkusega patsientidel. adrovance vähendab lülisamba ja puusaluu murrud.

Euroopa Liit - eesti - EMA (European Medicines Agency)

glaxo group ltd - retapamuliin - impetigo; staphylococcal skin infections - antibiootikumid ja kemoterapeutikumid dermatoloogiliseks kasutamiseks - short term treatment of the following superficial skin infections: , impetigo;, infected small lacerations, abrasions or sutured wounds. vt punkte 4. 4 ja 5. 1 oluline teave kliinilise tegevuse retapamulin vastu erinevad liigid staphylococcus aureus. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.